logo

For the Inventor, By the Inventor

Rehovot, Israel

Steven J D Karlish

This inventor holds 4 USPTO granted patents. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2011-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven J D Karlish. Retrieved from https://idiyas.com/inventor/steven-j-d-karlish

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 75.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Rechovot, IL (2011)
  • Rehovot, IL (2018 - 2021)

Company Filing History:

goldMedal4 out of 1,168 
 
Yeda Research and Develpment & Co. Ltd
 patents

Years Active: 2011-2021

Loading Chart...
4 patents (USPTO):Explore Patents
1. 11077128 - Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure (2021-08-03),
2. 10668094 - Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure (2020-06-02),
3. 9938316 - Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents (2018-04-10),
4. 7888059 - Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same (2011-02-15),

Title: The Innovations of Steven J D Karlish

Introduction

Steven J D Karlish is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of medical science, particularly in the development of selective inhibitors for Na,K-ATPase. With a total of 4 patents to his name, his work has implications for treating various health conditions, including glaucoma and heart diseases.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure." This patent describes alpha2-selective Na,K-ATPase inhibitors and prodrugs characterized by having a cyclic moiety attached to a digoxin or digitoxin derivative. The invention aims to lower intraocular pressure and offers potential treatments for glaucoma and heart conditions.

Career Highlights

Steven J D Karlish is associated with Yeda Research and Development Co. Ltd., where he continues to innovate and contribute to scientific advancements. His work is recognized for its potential impact on healthcare and the treatment of serious medical conditions.

Collaborations

He has collaborated with notable coworkers, including Adriana Katz and Daniel M Tal, who share his commitment to advancing medical research and innovation.

Conclusion

Steven J D Karlish's contributions to the field of medical science through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in treatments for critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…